Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Redefining the Normal: Ultra-High Frequency Ultrasound Characterization of Lymphatic Anatomy in Patients With Breast Cancer

NCT07677839 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT07677839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07677839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Redefining the Normal: Ultra-High Frequency Ultrasound Characterization of Lymphatic Anatomy in Patients With Breast Cancer
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Recruiting
Start date
June 17, 2026
Completion date
September 1, 2036
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer